These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 38919514)
1. Endoscopic findings and outcomes of gastric mucosal changes relating to potassium-competitive acid blocker and proton pump inhibitor therapy. Shinozaki S; Osawa H; Miura Y; Nomoto H; Sakamoto H; Hayashi Y; Yano T; Despott EJ; Yamamoto H DEN Open; 2025 Apr; 5(1):e400. PubMed ID: 38919514 [TBL] [Abstract][Full Text] [Related]
2. The effect of proton pump inhibitors and vonoprazan on the development of 'gastric mucosal redness'. Shinozaki S; Osawa H; Miura Y; Hayashi Y; Sakamoto H; Yano T; Kawarai Lefor A; Yamamoto H Biomed Rep; 2022 Jun; 16(6):51. PubMed ID: 35620314 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux. Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M Digestion; 2020; 101(2):174-183. PubMed ID: 30897577 [TBL] [Abstract][Full Text] [Related]
4. Long-term endoscopic change of gastric polyp associated with administration of vonoprazan. Ochiai Y; Ito S; Kikuchi D; Hoteya S Clin J Gastroenterol; 2024 Aug; 17(4):598-601. PubMed ID: 38575803 [TBL] [Abstract][Full Text] [Related]
5. Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Sue S; Maeda S Gut Liver; 2021 Nov; 15(6):799-810. PubMed ID: 33850058 [TBL] [Abstract][Full Text] [Related]
8. Treatment of Kanu JE; Soldera J World J Gastroenterol; 2024 Mar; 30(9):1213-1223. PubMed ID: 38577188 [TBL] [Abstract][Full Text] [Related]
9. A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: A systematic review and meta-analysis. Simadibrata DM; Syam AF; Lee YY J Gastroenterol Hepatol; 2022 Dec; 37(12):2217-2228. PubMed ID: 36181401 [TBL] [Abstract][Full Text] [Related]
10. The Ameliorating Effect of Switching to Vonoprazan: A Novel Potassium-Competitive Acid Blocker in Patients with Proton Pump Inhibitor Refractory Non-Erosive Reflux Disease. Abe Y; Koike T; Saito M; Okata T; Nakagawa K; Hatta W; Asanuma K; Uno K; Asano N; Imatani A; Masamune A Digestion; 2021; 102(3):480-488. PubMed ID: 32062650 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of Vonoprazan for Refractory Reflux Esophagitis after Esophagectomy. Ochiai Y; Iizuka T; Hoshihara Y; Suzuki Y; Hayasaka J; Nomura K; Tanaka M; Odagiri H; Yamashita S; Matsui A; Kikuchi D; Ueno M; Udagawa H; Hoteya S Dig Dis; 2021; 39(6):569-576. PubMed ID: 33567428 [TBL] [Abstract][Full Text] [Related]
15. Role of Vonoprazan in Sugimoto M; Yamaoka Y Front Pharmacol; 2018; 9():1560. PubMed ID: 30697158 [TBL] [Abstract][Full Text] [Related]
16. Examination on Factors Affecting Symptom Change after Drug Withdrawal in Patients with Mild Erosive Gastroesophageal Reflux Disease Undergoing Symptom-Controlled Maintenance Therapy with Acid-Secretion Inhibition Drugs. Tanaka H; Takeuchi T; Nishida S; Hongo H; Takii M; Higashino T; Sanomura M; Miyazaki H; Hoshimoto M; Kimura T; Sakaguchi M; Abe T; Hakoda A; Sugawara N; Iwatsubo T; Kawaguchi S; Ota K; Kojima Y; Higuchi K Digestion; 2023; 104(4):270-282. PubMed ID: 36649678 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of Vonoprazan versus Proton Pump Inhibitors for Second-Line Helicobacter pylori Eradication Therapy: Systematic Review and Meta-Analysis. Shinozaki S; Kobayashi Y; Osawa H; Sakamoto H; Hayashi Y; Lefor AK; Yamamoto H Digestion; 2021; 102(3):319-325. PubMed ID: 31914442 [TBL] [Abstract][Full Text] [Related]
18. The Potential Benefits of Vonoprazan as Miftahussurur M; Pratama Putra B; Yamaoka Y Pharmaceuticals (Basel); 2020 Sep; 13(10):. PubMed ID: 32998241 [No Abstract] [Full Text] [Related]
19. Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in Japan. Hongo M; Fujimoto K; J Gastroenterol; 2010 Jun; 45(6):618-24. PubMed ID: 20177714 [TBL] [Abstract][Full Text] [Related]
20. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition. Fossmark R; Jianu CS; Martinsen TC; Qvigstad G; Syversen U; Waldum HL Scand J Gastroenterol; 2008 Jan; 43(1):20-4. PubMed ID: 18938772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]